- Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. Al Ali, S.H., Al-Qubaisi, M., Hussein, M.Z., Ismail, M., Zainal, Z., Hakim, M.N. Int. J. Nanomedicine (2012)